CHM
Click for more information
5.26% 1.8¢ chimeric therapeutics limited

Indeed. “The FDA clearance of our IND is a critical milestone...

  1. GWR
    79 Posts.
    lightbulb Created with Sketch. 17
    clock Created with Sketch.
    20/08/21
    09:42
    Post #: 55435062
    Indeed. “The FDA clearance of our IND is a critical milestone for Chimeric as it enables us to expand the
    development program for CHM 1101 (CLTX CAR T),” said Jennifer Chow, COO Chimeric
    Therapeutics."
    CHM Price at posting: 31.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.8¢ 		Change
-0.001(5.26%) 		Mkt cap ! $15.76M
Open High Low Value Volume
1.9¢ 1.9¢ 1.8¢ $11.89K 649.8K

Buyers (Bids)

No. Vol. Price($)
12 1675567 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 158684 2
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.